Learning to manage addiction can be difficult, and with abuse of more than one drug, a person will likely need an intensive program tailored to their specific needs. Some drugs can cause life-threatening forms of withdrawal, including alcohol, while others aren’t always life-threatening but can be so uncomfortable a person is likely to relapse without medical help in detox. People who began using substances at an early age are more likely to develop addiction later in life, the NIDA states. How a person abuses a drug is also a factor—when a person abuses a drug by a method of administration that produces instant effects, such as by smoking or injection, he or she is more likely to quickly develop an addiction to it. Drugs interrupt brain communication pathways by binding to receptors and altering the processes in the brain.
Stop Overdose
In response, prevention and treatment practices and policies have been implemented widely [5, 11]. However, if the “opioid crisis” includes multiple substances, the opioid specificity of current prevention and treatment interventions may limit their ability to address the broader problem of polysubstance use involving opioids. To have the maximum impact on this multifaceted crisis, it is important to understand the overlap of opioids with other substances. However, although both GABA and DA neurons in the VTA express GABAAR, benzodiazepines bind to those containing the α1 subunit, which are localized to VTA-GABA neurons and are lacking in VTA-DA neurons [78,79,80]. Long-term use of psychostimulants, nicotine, opioids, cannabinoids, and alcohol results in widespread and disparate changes throughout the C-BG-T network, yet there are notable alterations that are shared across drugs (Figure 5).
Getting treatment for polysubstance abuse
Psychostimulants are the second-most widely used class of drugs, with 18 million current cocaine users and 29 million current prescription stimulant users worldwide (United Nations Office on Drugs and Crime, 2019). Worldwide prevalence of psychostimulant use has remained relatively stable from 1990 to 2017, with 7.38 million reported to meet criteria for an amphetamine use disorder and 5.02 million reported to meet criteria for a cocaine use disorder (Degenhardt et al., 2018). However, the number of drug-related overdose deaths involving psychostimulants has continued to climb, especially in the US, with a 2.6-fold increase in the cocaine overdose death rate and 3.6-fold increase in the methamphetamine overdose death rate from 2000 to 2017 (Degenhardt et al., 2018). Depending on the substance of abuse, a person may require a medical detoxification before proceeding to addiction treatment. Alcohol, barbiturates, benzodiazepines, and opioids can all cause physical dependence, which means when a person tries to go off the drugs, they experience uncomfortable and, in some cases, dangerous withdrawal symptoms. It is not known exactly how many people in the United States are affected by polysubstance abuse and addiction.
Barbiturates, benzodiazepines and hypnotics
However, it is important to note that there is not a lab test that can establish dependence or addiction. Substance withdrawal involves experiencing physical, cognitive, and behavioral substance use amphetamines symptoms due to reducing or halting substance use. To be diagnosed with withdrawal, these symptoms must not be due to another mental disorder or medical condition.
Common combinations of drug classes
These studies further emphasize the need to consider use patterns and dose in interpretation of polydrug use effects. Given the unique neurobiological alterations that can occur with exposure to multiple drugs, along with the high prevalence of polysubstance use disorders, there is a strong need to develop polydrug paradigms that have high translational value. These paradigms are critical for fully understanding the behavioral changes and addiction-related phenotypes that develop following polydrug use. However, given the vast number of potential substance combinations and the variability in methodologies that exist across studies, there are currently mixed results and interpretations regarding the impact of polydrug history on addiction-related behaviors.
Nonetheless, some general trends in drug consumption, drug preference and drug-seeking have been demonstrated in commonly investigated substance combinations (Figure 2). Overlap of opioids with other substances can include shifts across the lifespan and simultaneous co-use of substances. Use of substances across a broad time frame (i.e., past year or lifetime) is typical for epidemiological studies, which less commonly assess specific co-use patterns within specific drug using occasions. Similar to psychostimulants, long-term nicotine administration what are whippits and how can they be abused reduces GABAB-mediated signaling in the mPFC and NAc (Amantea et al., 2004), dampening inhibitory drive onto the C- BG-T network. Additionally, nicotine enhances glutamatergic input to VTADA neurons (Mansvelder and McGehee, 2000; Saal et al., 2003), and sensitizes evoked DA release into the NAc (Benwell et al., 1995). Repeated nicotine use also leads to an upregulation of nicotinic acetylcholine receptors throughout the C-BG-T, including the PFC and midbrain (Marks et al., 1983; Benwell et al., 1988; Breese et al., 1997).
Clinicians can also add “in early remission,” “in sustained remission,” “on maintenance therapy” for certain substances, and “in a controlled environment.” These further describe the current state of the substance use disorder. The DSM-5-TR allows clinicians to specify how severe or how much of a problem the substance use disorder is, depending on how many symptoms are identified. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
- Treating co-occurring disorders can be more challenging, as it’s important that both disorders are properly diagnosed and treated or a person’s recovery outcome may be affected.
- To diagnose a substance use disorder, a healthcare practitioner will evaluate the individual by completing a physical exam and taking a medical history.
- Three reviewers (MBF, GC, GG) independently assessed the quality of included studies using the Mixed Methods Appraisal Tool (MMAT).26,27 This tool has been developed and validated to critically appraise the methodological quality of different study designs.
- Barbiturates, benzodiazepines and hypnotics are prescription central nervous system depressants.
- Nadia Allami and Kristen O’Connor provided care for the case study patient and drafted the initial case report manuscript.
Some commonly inhaled substances include glue, paint thinners, correction fluid, felt tip marker fluid, gasoline, cleaning fluids and household aerosol products. Due to the toxic nature of these substances, users may develop brain damage or sudden death. Examples include methylenedioxymethamphetamine, also called MDMA, ecstasy or molly, and gamma-hydroxybutyric acid, known as GHB. Other examples include ketamine and flunitrazepam or Rohypnol — a brand used outside the U.S. — also called roofie. These drugs are not all in the same category, but they share some similar effects and dangers, including long-term harmful effects. The use of fentanyl alongside stimulants is “rapidly becoming the dominant force in the U.S. overdose crisis,” Joseph Friedman, the study’s lead author and a researcher at UCLA’s David Geffen School of Medicine, told NPR.
In addition, route of drug administration (e.g. oral ingestion, injection, and inhalation) is especially important to factor into studies, as it leads to unique patterns of polysubstance history that may impact the developmentand severity of addiction behaviors (Roy et al., 2013). Limited work has focused on the effects of polydrug use on nicotine-induced addiction behaviors. However, it has been found that THC pretreatment can enhance nicotine consumption and price inelasticity (measured by α) in behavioral economic tests in rats (Panlilio et al., 2013), and heroin intake has been found to increase cigarette consumption in people (Mello et al., 1980). In addition, pre-exposure to alcohol or simultaneous access to both alcohol and nicotine decreases nicotine self-administration in rodent studies (Lê et al., 2010, 2014). Although access to alcohol has no effect on responding for nicotine under extinction conditions, a priming dose of alcohol does reinstate nicotine-seeking (Lê et al., 2010).
Overall, the field needs to further understand the impact polysubstance use has on current available treatments, so that future research can better consider evidence for tailored treatment approaches. We also highlight the potential importance of careful translation of preclinical research to human studies. For example, preclinical models of drug reward (i.e., Fig. 2) could be updated with clinical research to identify which pathways and receptors are related to different substances in humans.
These studies permit comparison of perceived value across multiple drugs in participants with histories of single or polysubstance use (for further review, see Heinz et al., 2012). Improving the translatability and mapping of behavioral measures in preclinical models to accurately reflect polysubstance history and dependency in clinical populations is essential. This is particularly true, as human imaging studies are limited by an inability to control for intake history, making behavioral models in other species advantageous for assessing polydrug history under controlled intake conditions. However, these models are limited in their capacity to fully encompass the complex social and environmental contexts that contribute to the unique use patterns for multiple substances with addiction potential. Nevertheless, when designing experiments in clinical or preclinical populations, factors such as time of day of intake, temporal proximity of intake, and environmental preferences for administration must be consideredfor each substance class. For instance, cocaine use is predominantly favored outside of home environments, whereas heroin use is greater in “home” contexts in both humans and rodents (Caprioli et al., 2009; Badiani and Spagnolo, 2013; De Pirro et al., 2018; De Luca et al., 2019).
For example, psychostimulants acutely increase activation of the immediate early gene Fos in striatal dMSNs and iMSNs (Badiani et al., 1999; Uslaner et al., 2001; Ferguson and Robinson, 2004). Fos encodes a number of proteins, including ΔFosB, that have been widely implicated in addiction pathology, and enhanced activation in the NAc is thought to contribute to long-term disruptions in normal C-BG-T activity (Nestler et al., 2001). Co-administration of nicotine, alcohol, or heroin enhances psychostimulant-induced DA release into the NAc (Bunney et al., 2001; Mello et al., 2014; Pattison et al., 2014), though specific combinations do so via divergent mechanisms. For example, administration of cocaine and nicotine simultaneously activates VTADA neurons and disrupts DA reuptake (Mello et al., 2014; De Moura et al., 2019), resulting in a greater magnitude of DA release into the NAc than that evoked from either drug alone. Notably, some polydrug combinations that include psychostimulants have divergent and opposing effects on the C-BG-T circuit.
In support of this hypothesis, alcohol inhibits VTAGABA neurons (Steffensen et al., 2009), and intra-VTA infusion of GABAA agonists dose-dependently increase DA release (Kalivas et al., 1990). In addition to GABA, the acute effects of alcohol are dependent on glutamatergic signaling within the C-BG-T (Grant and Colombo, 1993; Krystal et al., 1994). Alcohol detoxing from benzos: how to do it safely a guide increases glutamate release in the NAc and VTA via activation of presynaptic D1 receptors (Nie et al., 1994; Xiao et al., 2009), suggesting that alcohol engages a feedforward loop for activation of VTADA neurons. Polydrug use with alcohol produces synergistic effects throughout the C-BG-T, likely as a result of alcohol’s unique pharmacological profile.
Once the list of motivations stabilized, two reviewers (either MBF and CL, or MBF and GC) coded the verbatims separately and then compared their results. If the reviewers disagreed as to the motivation to ascribe, they resolved the disagreement through discussion, with a third reviewer joining the discussion if the disagreement persisted. Persistent disruptions in synaptic and structural plasticity caused by long-term use of potentially addictive drugs.
For instance, if a substance is illicit (illegal), such as heroin or cocaine, then use of it is always considered abuse. Cocaine typically leads to elevated mood and energy, while benzos like Valium (diazepam) or Xanax (alprazolam) are sedatives often used to help you sleep. The benefit of providing a medical home to offer outpatient addiction treatment for adolescents holds significant potential. For adolescents, who often have ambivalence about their use and may not want to be treated with MOUD indefinitely, they can remain engaged with a trusted treatment team. This primary care engagement ensures an infrastructure to allow for seamless re-initiation of MOUD or other behavioral treatment if desired by patient or indicated. Currently, fewer than 5% of adolescents in the United States with OUD are offered MOUD [12].